Gencurix Inc

XKRX:229000 (Korea (the Republic of))  
â‚© 3010.00 (-0.66%) Apr 25
At Loss
P/B:
3.02
Market Cap:
â‚© 38.80B ($ 28.16M)
Enterprise V:
â‚© 44.45B ($ 32.27M)
Volume:
62.66K
Avg Vol (2M):
217.76K
Volume:
62.66K
At Loss
PE Ratio PS Ratio PB Ratio Price-to-FCF Market Cap
Current and historical daily PE Ratio for Gencurix Inc ( ) from 2015 to Apr 26 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Gencurix stock (XKRX:229000) PE ratio as of Apr 26 2024 is 0. More Details

Gencurix Inc (XKRX:229000) PE Ratio (TTM) Chart

To

Gencurix Inc (XKRX:229000) PE Ratio (TTM) Historical Data

Total 1122
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 13
Gencurix PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2024-04-26 At Loss 2024-02-21 At Loss
2024-04-25 At Loss 2024-02-20 At Loss
2024-04-24 At Loss 2024-02-19 At Loss
2024-04-23 At Loss 2024-02-16 At Loss
2024-04-22 At Loss 2024-02-15 At Loss
2024-04-19 At Loss 2024-02-14 At Loss
2024-04-18 At Loss 2024-02-13 At Loss
2024-04-17 At Loss 2024-02-08 At Loss
2024-04-16 At Loss 2024-02-07 At Loss
2024-04-15 At Loss 2024-02-06 At Loss
2024-04-12 At Loss 2024-02-05 At Loss
2024-04-11 At Loss 2024-02-02 At Loss
2024-04-09 At Loss 2024-02-01 At Loss
2024-04-08 At Loss 2024-01-31 At Loss
2024-04-05 At Loss 2024-01-30 At Loss
2024-04-04 At Loss 2024-01-29 At Loss
2024-04-03 At Loss 2024-01-26 At Loss
2024-04-02 At Loss 2024-01-25 At Loss
2024-04-01 At Loss 2024-01-24 At Loss
2024-03-29 At Loss 2024-01-23 At Loss
2024-03-28 At Loss 2024-01-22 At Loss
2024-03-27 At Loss 2024-01-19 At Loss
2024-03-26 At Loss 2024-01-18 At Loss
2024-03-25 At Loss 2024-01-17 At Loss
2024-03-22 At Loss 2024-01-16 At Loss
2024-03-21 At Loss 2024-01-15 At Loss
2024-03-20 At Loss 2024-01-12 At Loss
2024-03-19 At Loss 2024-01-11 At Loss
2024-03-18 At Loss 2024-01-10 At Loss
2024-03-15 At Loss 2024-01-09 At Loss
2024-03-14 At Loss 2024-01-08 At Loss
2024-03-13 At Loss 2024-01-05 At Loss
2024-03-12 At Loss 2024-01-04 At Loss
2024-03-11 At Loss 2024-01-03 At Loss
2024-03-08 At Loss 2024-01-02 At Loss
2024-03-07 At Loss 2023-12-28 At Loss
2024-03-06 At Loss 2023-12-27 At Loss
2024-03-05 At Loss 2023-12-26 At Loss
2024-03-04 At Loss 2023-12-22 At Loss
2024-02-29 At Loss 2023-12-21 At Loss
2024-02-28 At Loss 2023-12-20 At Loss
2024-02-27 At Loss 2023-12-19 At Loss
2024-02-26 At Loss 2023-12-18 At Loss
2024-02-23 At Loss 2023-12-15 At Loss
2024-02-22 At Loss 2023-12-14 At Loss

Gencurix Inc (XKRX:229000) PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Description
Gencurix Inc develops diagnosis treatment kits. It offers products including GenesWell BCT, a breast cancer test; GenesWell ddEGFR Mutation Test; GenesWell CDx EGFR Mutation Test; and GenesWell ddEGFR mutation Test.